218 related articles for article (PubMed ID: 22856549)
21. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
[TBL] [Abstract][Full Text] [Related]
22. Profiling primaquine metabolites in primary human hepatocytes using UHPLC-QTOF-MS with 13C stable isotope labeling.
Avula B; Tekwani BL; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan SI; Adelli VR; Sahu R; Elsohly MA; McChesney JD; Khan IA; Walker LA
J Mass Spectrom; 2013 Feb; 48(2):276-85. PubMed ID: 23378100
[TBL] [Abstract][Full Text] [Related]
23. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data.
Li XQ; Björkman A; Andersson TB; Gustafsson LL; Masimirembwa CM
Eur J Clin Pharmacol; 2003 Sep; 59(5-6):429-42. PubMed ID: 12920490
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of 8-aminoquinoline antimalarial agents.
Strother A; Fraser IM; Allahyari R; Tilton BE
Bull World Health Organ; 1981; 59(3):413-25. PubMed ID: 6976849
[TBL] [Abstract][Full Text] [Related]
25. PFMDR1 POLYMORPHISMS INFLUENCE ON IN VITRO SENSITIVITY OF THAI PLASMODIUM FALCIPARUM ISOLATES TO PRIMAQUINE, SITAMAQUINE AND TAFENOQUINE.
Kaewpruk N; Tan-ariya P; Ward SA; Sitthichot N; Suwandittakul N; Mungthin M
Southeast Asian J Trop Med Public Health; 2016 May; 47(3):366-76. PubMed ID: 27405118
[TBL] [Abstract][Full Text] [Related]
26. In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.
Daher W; Pelinski L; Klieber S; Sadoun F; Meunier V; Bourrié M; Biot C; Guillou F; Fabre G; Brocard J; Fraisse L; Maffrand JP; Khalife J; Dive D
Drug Metab Dispos; 2006 Apr; 34(4):667-82. PubMed ID: 16415117
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.
Milner EE; Berman J; Caridha D; Dickson SP; Hickman M; Lee PJ; Marcsisin SR; Read LT; Roncal N; Vesely BA; Xie LH; Zhang J; Zhang P; Li Q
Malar J; 2016 Dec; 15(1):588. PubMed ID: 27923405
[TBL] [Abstract][Full Text] [Related]
28. Primaquine for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
[TBL] [Abstract][Full Text] [Related]
29. Comparative metabolism and tolerability of racemic primaquine and its enantiomers in human volunteers during 7-day administration.
Khan W; Wang YH; Chaurasiya ND; Nanayakkara NPD; Bandara Herath HM; Harrison KA; Dale G; Stanford DA; Dahl EP; McChesney JD; Gul W; ElSohly MA; Jollow D; Tekwani BL; Walker LA
Front Pharmacol; 2022; 13():1104735. PubMed ID: 36726785
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization, and cellular localization of a fluorescent probe of the antimalarial 8-aminoquinoline primaquine.
McQueen A; Blake LD; Azhari A; Kemp MT; McGaha TW; Namelikonda N; Larsen RW; Manetsch R; Kyle DE
Bioorg Med Chem Lett; 2017 Oct; 27(20):4597-4600. PubMed ID: 28939120
[TBL] [Abstract][Full Text] [Related]
31. Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.
Xuan J; Chen S; Ning B; Tolleson WH; Guo L
Chem Biol Interact; 2016 Aug; 255():63-73. PubMed ID: 26477383
[TBL] [Abstract][Full Text] [Related]
32. CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater fever.
Marcsisin SR; Jin X; Bettger T; McCulley N; Sousa JC; Shanks GD; Tekwani BL; Sahu R; Reichard GA; Sciotti RJ; Melendez V; Pybus BS
Malar J; 2013 Jun; 12():214. PubMed ID: 23800033
[TBL] [Abstract][Full Text] [Related]
33. Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
J Pharmacol Exp Ther; 2001 Apr; 297(1):326-37. PubMed ID: 11259560
[TBL] [Abstract][Full Text] [Related]
34. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
[TBL] [Abstract][Full Text] [Related]
35. Primaquine treatment and relapse in Plasmodium vivax malaria.
Rishikesh K; Saravu K
Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
[TBL] [Abstract][Full Text] [Related]
36. The conversion of primaquine into primaquine-aldehyde, primaquine-alcohol, and carboxyprimaquine, a major plasma metabolite.
Frischer H; Mellovitz RL; Ahmad T; Nora MV
J Lab Clin Med; 1991 Jun; 117(6):468-76. PubMed ID: 2045714
[TBL] [Abstract][Full Text] [Related]
37. Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.
Portela MJ; Moreira R; Valente E; Constantino L; Iley J; Pinto J; Rosa R; Cravo P; do Rosário VE
Pharm Res; 1999 Jun; 16(6):949-55. PubMed ID: 10397619
[TBL] [Abstract][Full Text] [Related]
38. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Ericsson T; Sundell J; Torkelsson A; Hoffmann KJ; Ashton M
Xenobiotica; 2014 Jul; 44(7):615-26. PubMed ID: 24400699
[TBL] [Abstract][Full Text] [Related]
39. Primaquine revisited six decades after its discovery.
Vale N; Moreira R; Gomes P
Eur J Med Chem; 2009 Mar; 44(3):937-53. PubMed ID: 18930565
[TBL] [Abstract][Full Text] [Related]
40. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy.
Dierling AM; Cui Z
Int J Pharm; 2005 Oct; 303(1-2):143-52. PubMed ID: 16140485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
